{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:02:49Z","timestamp":1781708569532,"version":"3.54.5"},"reference-count":67,"publisher":"Informa UK Limited","funder":[{"name":"Northwestern Medicine, Department of Psychiatry and Behavioral Sciences"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychoactive Drugs"],"DOI":"10.1080\/02791072.2026.2686369","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:36:27Z","timestamp":1781706987000},"page":"1-25","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Barbiturates for the Management of Gamma-Hydroxybutyrate (GHB) Withdrawal: A Systematic Review"],"prefix":"10.1080","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3768-0243","authenticated-orcid":false,"given":"Gayane","family":"Archer","sequence":"first","affiliation":[{"name":"Northwestern University","place":["Chicago, USA"]},{"name":"Northwestern Medicine","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9036-717X","authenticated-orcid":false,"given":"Alyssa","family":"Bernanke","sequence":"additional","affiliation":[{"name":"Northwestern University","place":["Chicago, USA"]},{"name":"Northwestern Medicine","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1135-757X","authenticated-orcid":false,"given":"Cecilia N.","family":"Hollenhorst","sequence":"additional","affiliation":[{"name":"Northwestern University","place":["Chicago, USA"]},{"name":"Northwestern Medicine","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Yu","sequence":"additional","affiliation":[{"name":"Northwestern University","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9753-4292","authenticated-orcid":false,"given":"Brent","family":"Schnipke","sequence":"additional","affiliation":[{"name":"Northwestern University","place":["Chicago, USA"]},{"name":"Northwestern Medicine","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Gershan","sequence":"additional","affiliation":[{"name":"Northwestern University","place":["Chicago, USA"]},{"name":"Northwestern Medicine","place":["Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"6","key":"e_1_3_4_2_1","first-page":"1443","article-title":"Alcohol withdrawal syndrome","volume":"69","author":"Bayard M.","year":"2004","unstructured":"Bayard, M., J. Mcintyre, K. R. Hill, and J. Woodside. 2004. Alcohol withdrawal syndrome. American Family Physician 69 (6):1443\u201350. Accessed September 30, 2024. https:\/\/www.aafp.org\/pubs\/afp\/issues\/2004\/0315\/p1443.html.","journal-title":"American Family Physician"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0193-953x(03)00060-1"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.70013"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2017.01.022"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(01)01334-6"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.42.1.83"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/j.1440-1665.2004.02142.x"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0736-4679(99)00163-8"},{"issue":"3","key":"e_1_3_4_10_1","first-page":"354","article-title":"Inpatient management of GHB\/GBL withdrawal","volume":"31","author":"Delic M.","year":"2019","unstructured":"Delic, M. 2019. Inpatient management of GHB\/GBL withdrawal. Psychiatria Danubina 31 (Suppl 3):354\u201356. PMID: 31488752.","journal-title":"Psychiatria Danubina"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.11.014"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.17161\/kjm.v12i2.11702"},{"key":"e_1_3_4_13_1","author":"Drug Enforcement Administration","year":"2025","unstructured":"Drug Enforcement Administration. 2025a. 1,4-Butanediol Last Modified August 2025. Accessed December 22, 2025. https:\/\/www.deadiversion.usdoj.gov\/drug_chem_info\/bdo.pdf.","journal-title":"1,4-Butanediol Last Modified August 2025"},{"key":"e_1_3_4_14_1","unstructured":"Drug Enforcement Administration. 2025b. Gamma-butyrolactone. Last modified August 2025. Accessed December 22 2025. https:\/\/deadiversion.usdoj.gov\/drug_chem_info\/gbl.pdf."},{"key":"e_1_3_4_15_1","unstructured":"Drug Enforcement Administration. 2025c. Gamma hydroxybutyric acid. Last modified October 2025. Accessed December 22 2025. https:\/\/www.deadiversion.usdoj.gov\/drug_chem_info\/ghb.pdf."},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2001.112985"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e3182236730"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-00543-z"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2387-z"},{"key":"e_1_3_4_20_1","unstructured":"Food and Drug Administration. 2002. Xyrem: Original approval. Last modified July 17 2002. Accessed September 25 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2002\/21196ltr.pdf."},{"key":"e_1_3_4_21_1","unstructured":"Food and Drug Administration. 2005. Xyrem: Efficacy-new indication. Last modified November 18 2005. Accessed September 25 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2005\/021196s005ltr.pdf."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13556"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb03640.x"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pra.0000452567.84825.07"},{"key":"e_1_3_4_25_1","unstructured":"Haber P. N. Lintzeris E. Proude and O. Lopatko. 2009. Quick reference guide to the treatment of alcohol problems: Companion document to the guidelines for the treatment of alcohol problems. Canberra: Australian Government Commonwealth Department of Health and Ageing. Last modified June 2009. Accessed October 6 2024. https:\/\/www.drugsandalcohol.ie\/20201\/1\/Gudelines_for_treatment_of_alcohol_problems.pdf."},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000514"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14488"},{"key":"e_1_3_4_28_1","unstructured":"Jazz Pharmaceuticals P. L. C. 2025. Xyrem\u00ae prescribing information. Last modified July 2025. https:\/\/pp.jazzpharma.com\/pi\/xyrem.en.USPI.pdf."},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12671"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/1742-6723.12721"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0402-z"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-013-0158-x"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-021-03182-w"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25728"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1017\/cem.2019.421"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-008-9062-2"},{"issue":"1","key":"e_1_3_4_37_1","first-page":"107","article-title":"Improved pharmacological activity via pro-drug modification: Comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone","volume":"22","author":"Lettieri J.","year":"1978","unstructured":"Lettieri, J., and H. L. Fung. 1978. Improved pharmacological activity via pro-drug modification: Comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone. Research Communications in Chemical Pathology and Pharmacology 22 (1):107\u201318. PMID: 725311.","journal-title":"Research Communications in Chemical Pathology and Pharmacology"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2018.06.005"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000431"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2012.01.012"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12347"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.2478\/aiht-2020-71-3314"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2001.10400479"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.01.012"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/105504901750532111"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00191-5"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2022.2081948"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2006.03.040"},{"key":"e_1_3_4_49_1","volume-title":"Wolters Kluwer","author":"Phenobarbital: Drug information","year":"2025","unstructured":"Phenobarbital: Drug information. 2025. UpToDate. In Wolters Kluwer, ed. Connor. RF. Accessed May 4, 2025."},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc13883"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1081\/ADA-120020529"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2012.702218"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028016629161"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0736-4679(01)00324-9"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-3450"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06283-6"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.4103\/0971-9784.69057"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2001.119454"},{"key":"e_1_3_4_59_1","unstructured":"Skibiski J. P. Patel and S. Abdijadid. 2025. Barbiturates. StatPearls. Statpearls publishing. Accessed May 4 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539731\/."},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2022.02.020"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.2165\/00139709-200423010-00005"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja16.00269"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33695"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2014.03.002"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2020.1827124"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.767"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1017\/s1481803500010034"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1224163"}],"container-title":["Journal of Psychoactive Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02791072.2026.2686369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:36:46Z","timestamp":1781707006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02791072.2026.2686369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":67,"alternative-id":["10.1080\/02791072.2026.2686369"],"URL":"https:\/\/doi.org\/10.1080\/02791072.2026.2686369","relation":{},"ISSN":["0279-1072","2159-9777"],"issn-type":[{"value":"0279-1072","type":"print"},{"value":"2159-9777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}